A Clinical Evaluation of Anti-Inflammatory and Analgesic Activities of Curcuma longa Extract in Patients Suffering from Osteoarthritis of Knee(s) - An Open Labeled, Multi-Centric, Interventional, Prospective Study

Anti-Inflammatory and Analgesic Activities of Curcuma longa Extract in Osteoarthritis of Knee(s)

Authors

  • Dr. Maya Gokhale Sane Guruji Hospital, Malwadi, Hadapsar Pune, Maharashtra, India
  • Dr. Pranita Joshi Sane Guruji Hospital, Malwadi, Hadapsar Pune, Maharashtra, India
  • Dr. Swapnali Mahadik Target Institute of Medical Education & Research, Mumbai
  • Dr. Ruby Dubey Target Institute of Medical Education & Research, Mumbai
  • Dr. Vinay Pawar D. Y. Patil Deemed to be University School of Ayurveda, Nerul, Navi Mumbai - 400 607 https://orcid.org/0000-0001-8349-9668
  • Ms. Kiran Khatau Lodaat Pharma, USA
  • Dr. Sanjay Tamoli Target Institute of Medical Education and Research, Mumbai, India

DOI:

https://doi.org/10.53555/ans.v8i2.2003

Keywords:

OA disease, Osteoarthritis, Turmeric, Curcuma longa

Abstract

Background: Curcumin, the principal curcuminoid in turmeric, is a biologically active phytochemical which may exert a chondroprotective effect through actions such as anti-inflammatory, anti-oxidative stress and anti-catabolic activity that are critical for mitigating OA disease pathogenesis and symptoms. A proprietary water soluble turmeric extract of Curcuma longa standardized to not less than 23% total Curcuminoids (AQUATURM®) was studied for its anti-inflammatory & analgesic activity.

Objective: The objective was to evaluate efficacy and safety of Curcuma longa Extract in patients suffering from osteoarthritis of knee(s).

Methodology: After the ethics committee’s approval, subsequent CTRI registration, 21 patients suffering from OA attending OPD of the study center and who consented, were enrolled in the study after all necessary investigations. Subjects were advised to take Curcuma longa extract 900 mg (prepared as powder packets) dissolved in water and consumed daily for a period of 90 days.  After the baseline visit, subjects were called for follow-up visits on 30, 60, 90 days. All the subjects were closely monitored for any adverse events/ adverse drug reactions starting from the baseline visit.

Results:

The improvement in efficacy assessment parameters such as VAS Score of Knee(s) pain, WOMAC combined score, WOMAC Pain score, WOMAC Stiffness score and WOMAC Difficulty score was statistically significant (p < 0.05). At the end of study (90 days) the time taken to walk 50 feet was observed to be 20.18 ±3.02 sec which was found to be statistically significant. The study product was found to be safe and well tolerated.

Conclusion: It can be concluded that this proprietary Curcuma longa extract is a safe and effective natural supplement option for the management of osteoarthritis.

Downloads

Download data is not yet available.

References

Kolasinski SL, Neogi T, Hochberg MC, et al. American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis & Rheumatology. 2020; 72 (2): 220–233.

Felson DT, Laurence RC, Diepee Pa et al; Ann. Intern. Med; 133(9); 726-737: 2000.

Chopra A, Goregaonkar AB, Maroli S et al; Randomized double blind study to document Efficacy and Safety of Refecoxib + Betacyclodextrin complex in comparison with Rofecoxib in Patients suffering from Osteoarthritis; Ind. Med. Gazette. 2002: 180-196.

Lespasio MJ, Piuzzi NS, Husni ME, Muschler GF, Guarino A, Mont MA. Knee Osteoarthritis: A Primer. Perm J. 2017; 21:16-183.

Hochberg MC, Altman RD et al Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee.American College of Rheumatology.; Arthritis Rheum. 1995 Nov; 38(11):1531-1536.

McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis. A systematic quality assessment and meta-analysis. JAMA. 2000; 283: 1469-75.

Evans JM, McMahon AD, McGilchrist MM, White G, Murray FE, McDevitt DG, et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. BMJ. 1995; 311: 22-26.

Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of non-steroidal anti-inflammatory drugs: A meta-analysis. Ann Intern Me. 1991; 115: 787-796.

Caldwell B, Aldington S, Weatherall M, Shirtcliffe P, Beasley R. Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. J R Soc Med 2006; 99: 132-40.

Hermann M, Ruschitzka F. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs. Ann Med. 2007; 39: 18-27.

Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006; 332: 1302-1308.

Motsko SP, Rascati KL, Busti AJ, Wilson JP, Barner JC, Lawson KA, et al. Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk. Drug Saf. 2006; 29:621-32.

Henrotin Y, Priem F, Mobasheri A. Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management. Springer plus. 2013; 2(1): 56.

Asher GN, Spelman K. Clinical utility of curcumin extract. Altern Ther Health Med. 2013; 19(2):20–22.

Zhuo Zhang, et. al. Curcumin slows osteoarthritis progression and relieves osteoarthritis-associated pain symptoms in a post-traumatic osteoarthritis mouse model. Arthritis Res Ther. 2016; 18: 128.

Sharon L, Reginald H, Alexander A. Knee osteoarthritis in women. Curr Rev Musculoskelet Med. 2013; 6(2): 182–187.

Akuri MC, Barbalho SM, Val RM, et al. Reflections about Osteoarthritis and Curcuma longa. Pharmacogn Rev. 2017; 11(21): 8–12.

G F Ibironke, I O Owemidu. Analgesic activity of the ethanol extract of Curcuma longa rhizome and its mechanism of action. Niger J Physiol Sci. 2014 Jun 19; 29(1): 67-70.

Henrotin, Y., Priem, F., & Mobasheri, A. Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management. Springer Plus. 2013; 2(1): 56.

Vasavda Krup, Hedge Prakash L and Harini A. Pharmacological Activities of Turmeric (Curcuma longa linn): A Review. J Homeop Ayurv Med 2013, 2:4

Published

2022-03-31

How to Cite

Gokhale, M., Joshi, P., Mahadik, S., Dubey, R., Pawar, V., Khatau, K., & Tamoli, S. (2022). A Clinical Evaluation of Anti-Inflammatory and Analgesic Activities of Curcuma longa Extract in Patients Suffering from Osteoarthritis of Knee(s) - An Open Labeled, Multi-Centric, Interventional, Prospective Study: Anti-Inflammatory and Analgesic Activities of Curcuma longa Extract in Osteoarthritis of Knee(s). International Journal For Research In Applied And Natural Science, 8(2), 10–14. https://doi.org/10.53555/ans.v8i2.2003